AR229931A1 - Procedimiento para producir interferon de fibroblasto humano esencialmente purificado como proteina homogenea - Google Patents

Procedimiento para producir interferon de fibroblasto humano esencialmente purificado como proteina homogenea

Info

Publication number
AR229931A1
AR229931A1 AR282016A AR28201680A AR229931A1 AR 229931 A1 AR229931 A1 AR 229931A1 AR 282016 A AR282016 A AR 282016A AR 28201680 A AR28201680 A AR 28201680A AR 229931 A1 AR229931 A1 AR 229931A1
Authority
AR
Argentina
Prior art keywords
procedure
purified human
human fibroblast
produce interferon
essentially purified
Prior art date
Application number
AR282016A
Other languages
English (en)
Spanish (es)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of AR229931A1 publication Critical patent/AR229931A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/565IFN-beta
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AR282016A 1979-07-31 1980-07-31 Procedimiento para producir interferon de fibroblasto humano esencialmente purificado como proteina homogenea AR229931A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6237179A 1979-07-31 1979-07-31
US13063580A 1980-03-14 1980-03-14

Publications (1)

Publication Number Publication Date
AR229931A1 true AR229931A1 (es) 1984-01-31

Family

ID=26742182

Family Applications (1)

Application Number Title Priority Date Filing Date
AR282016A AR229931A1 (es) 1979-07-31 1980-07-31 Procedimiento para producir interferon de fibroblasto humano esencialmente purificado como proteina homogenea

Country Status (33)

Country Link
US (1) US5015730A (it)
JP (1) JPH02138226A (it)
AR (1) AR229931A1 (it)
AT (1) AT372387B (it)
AU (1) AU536274B2 (it)
CA (1) CA1146468A (it)
CH (1) CH648331A5 (it)
DE (1) DE3028919A1 (it)
DK (1) DK159825C (it)
DO (1) DOP1980002948A (it)
ES (1) ES8200560A1 (it)
FI (1) FI70721C (it)
FR (1) FR2462167B1 (it)
GB (1) GB2055384B (it)
HK (1) HK40384A (it)
HU (1) HU185382B (it)
IE (1) IE50075B1 (it)
IL (1) IL60697A (it)
IT (1) IT1132269B (it)
KE (1) KE3364A (it)
LU (1) LU82673A1 (it)
MC (1) MC1337A1 (it)
MY (1) MY8500274A (it)
NL (1) NL8004361A (it)
NO (1) NO151158C (it)
NZ (1) NZ194495A (it)
PH (2) PH17738A (it)
PT (1) PT71625B (it)
RO (1) RO81474B (it)
SE (1) SE466290B (it)
YU (1) YU193480A (it)
ZA (1) ZA803943B (it)
ZW (1) ZW17980A1 (it)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2687995B2 (ja) 1980-04-03 1997-12-08 バイオゲン インコーポレイテッド Dna配列、組替えdna分子およびヒト繊維芽細胞インターフェロン様ポリペプチドの製造方法
FR2490675B1 (fr) * 1980-09-25 1985-11-15 Genentech Inc Production microbienne d'interferon de fibroplaste humain
ZA83768B (en) * 1982-03-01 1983-10-26 Hoffmann La Roche Homogeneous human immune interferon and process therefor
US4966843A (en) * 1982-11-01 1990-10-30 Cetus Corporation Expression of interferon genes in Chinese hamster ovary cells
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
US4530787A (en) * 1984-03-28 1985-07-23 Cetus Corporation Controlled oxidation of microbially produced cysteine-containing proteins
US4894330A (en) * 1986-12-23 1990-01-16 Cetus Corporation Purification of recombinant beta-interferon incorporating RP-HPLC
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
US20030026779A1 (en) * 1999-10-15 2003-02-06 Liming Yu Treatment of tumors and viral infections with a hybrid conjugate of interferon and an immunoglobulin Fc
US20050002902A1 (en) * 1995-12-28 2005-01-06 Liming Yu Hybrid with interferon-alpha and an immunoglobulin Fc for treatment of tumors and viral infections
US20080219952A1 (en) 2005-08-26 2008-09-11 Ares Trading S.A. Process For the Preparation of Glycosylated Interferon Beta
EP1960419B1 (en) 2005-12-09 2016-03-16 Ares Trading S.A. Method for purifying fsh or a fsh mutant
AU2008314687A1 (en) * 2007-10-22 2009-04-30 Merck Serono S.A. Method for purifying Fc-fusion proteins
DE102009032179A1 (de) 2009-07-07 2011-01-13 Biogenerix Ag Verfahren zur Reinigung von Interferon beta

Also Published As

Publication number Publication date
IE801589L (en) 1981-01-31
FI70721C (fi) 1986-10-06
DK328880A (da) 1981-02-01
PH17738A (en) 1984-11-23
NZ194495A (en) 1984-07-31
JPH02138226A (ja) 1990-05-28
SE466290B (sv) 1992-01-27
DK159825C (da) 1991-04-29
DK159825B (da) 1990-12-10
MY8500274A (en) 1985-12-31
FI70721B (fi) 1986-06-26
RO81474A (ro) 1983-04-29
PT71625A (en) 1980-08-01
AU6091480A (en) 1981-02-05
IL60697A (en) 1984-04-30
NL8004361A (nl) 1981-02-03
PT71625B (en) 1981-12-17
ES493849A0 (es) 1981-11-16
ES8200560A1 (es) 1981-11-16
KE3364A (en) 1984-02-03
IL60697A0 (en) 1980-09-16
FR2462167A1 (fr) 1981-02-13
GB2055384B (en) 1983-08-10
IT8023801A0 (it) 1980-07-30
LU82673A1 (fr) 1982-02-17
CA1146468A (en) 1983-05-17
DOP1980002948A (es) 1989-04-20
GB2055384A (en) 1981-03-04
IE50075B1 (en) 1986-02-05
ZA803943B (en) 1981-06-24
NO151158C (no) 1985-02-20
ATA395080A (de) 1983-02-15
HU185382B (en) 1985-01-28
DE3028919C2 (it) 1988-02-18
SE8005498L (sv) 1981-02-01
FI802400A (fi) 1981-02-01
IT1132269B (it) 1986-07-02
NO151158B (no) 1984-11-12
CH648331A5 (de) 1985-03-15
RO81474B (ro) 1983-04-30
HK40384A (en) 1984-05-18
US5015730A (en) 1991-05-14
AU536274B2 (en) 1984-05-03
AT372387B (de) 1983-09-26
PH18479A (en) 1985-07-18
NO802297L (no) 1981-02-02
FR2462167B1 (fr) 1985-07-05
DE3028919A1 (de) 1981-02-19
MC1337A1 (fr) 1981-04-21
YU193480A (en) 1984-04-30
ZW17980A1 (en) 1981-03-18

Similar Documents

Publication Publication Date Title
AR229931A1 (es) Procedimiento para producir interferon de fibroblasto humano esencialmente purificado como proteina homogenea
IT1139487B (it) Produzione microbica di interferone di fibroblasti umani
ES490697A0 (es) Un metodo de producir proteinas de interferon humano de for-ma le
DK203187D0 (da) Human g-csf proteinekspression
DK478786D0 (da) Cystein-forarmede muteiner af biologisk aktive humantumornekrosefaktorproteiner
PT80292B (pt) Preparacao de factor viii humano funcional
BR8505074A (pt) Mascara de respiracao descartavel
NO149646C (no) Engangsbleie
ES491432A0 (es) Procedimiento para obtener agentes de tratamiento de fibras queratinicas
KR860005620A (ko) 소아용 트레이닝 팬츠 등과 같은 일회용 속팬츠
SE7800843L (sv) Till polyamid fixerat biologiskt aktivt protein och forfarande for dess framstellning
BR8003841A (pt) Quadro de comutacao encoberto
ES535509A0 (es) Procedimiento para purificar interferon de humano
SE7809014L (sv) Hudbehandlingskomposition
IT1036478B (it) Procedimento ed impianto per la fabricazione di libri cuciti
SE7805026L (sv) Aminohartskomposition i formfibrer
BR8007022A (pt) Fralda descartavel
DK31386A (da) Behandling af proliferative hudsygdomme
ES543524A0 (es) Procedimiento para preparar benzoxazolil- y benzotiazolil- aminoacidos
MX14287A (es) Procedimiento para preparar acidos oxoftalazinil-aceticos heterociclicos
DK194981A (da) Hudpraeparat
AR229097A1 (es) Imidas de acidos succinicos y procedimiento para prepararlas
MX161989A (es) Procedimiento para preparar metilester de alfa-l-aspartil-l-fenilalanina o clorhidrato del mismo
MX5066E (es) Procedimiento mejorado para la elaboracion de piridina y 3-metilpiridina
MX5672E (es) Procedimiento para la preparacion de acidos 2-piridil y 2-pirimidil-aminobenzoicos